BioGaia AB (publ) (STO:BIOG.B)
109.60
-0.70 (-0.63%)
At close: Mar 9, 2026
BioGaia AB Market Cap
BioGaia AB has a market cap or net worth of 11.16 billion as of March 9, 2026. Its market cap has decreased by -17.13% in one year.
Market Cap
11.16B
Enterprise Value
10.36B
Revenue
1.54B
Ranking
n/a
PE Ratio
33.53
Stock Price
109.60
Market Cap Chart
Since December 31, 1998, BioGaia AB's market cap has increased from 181.00M to 11.16B, an increase of 6,064.68%. That is a compound annual growth rate of 16.36%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.87B |
| EQL Pharma AB | 1.64B |
| Swedish Orphan Biovitrum AB | 130.18B |
| Orexo AB | 892.23M |
| Cinclus Pharma Holding AB | 797.66M |
| Nanexa AB | 649.29M |
| Dicot Pharma AB | 608.83M |
| Enzymatica AB | 495.18M |